Intas Pharmaceuticals Limited Syringe Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Syringe Export Records India — #11 Exporter, 35 Shipments, $1.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Syringe

India Pharmaceutical Trade Intelligence

$179.9M291 Suppliers154 CountriesHS 30049099

ExportsIndia → UNITED STATES36.7%India → BELGIUM14.1%

#1 Buyer: FRESENIUS KABI

Intas Pharmaceuticals Limited — Syringe Exporter #11 | $1.7M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Syringe Exporter Profile

Indian Pharmaceutical Exporter · #11 for Syringe · $1.7M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #11 Indian exporter of Syringe with $1.7M in export value and 35 verified shipments. Intas Pharmaceuticals Limited holds a 0.9% market share in Syringe exports across 11 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Syringe Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Syringe export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Syringe?

Country	Value	Shipments	Share
NETHERLANDS	$281.6K	7	21.3%
BRAZIL	$240.7K	6	18.2%
SPAIN	$204.0K	6	15.4%
UNITED STATES	$195.4K	4	14.8%
PERU

Who Are the Top Buyers of Syringe from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
BROCACEF NL : HUB	NETHERLANDS	$152.1K	4
AMERISOURCE HEALTH SERVICES	UNITED STATES	$145.4K	3
ACCORD FARMACEUTICA LTDA	BRAZIL	$140.7K	4
TO THE ORDER	ITALY	$136.1K	4
ACCORD FARMACEUTICA LTD	BRAZIL	$100.0K	2
FARMAVENIX	SPAIN	$98.0K	3
ALLOGA FRANCE	FRANCE	$95.6K	2
BROCACEF NL HUB BROCACEF HEALTHCAR	NETHERLANDS	$84.5K	2
FARMA VENIX	SPAIN	$55.9K	2
ACCORD HEALTHCARE S A C	PERU	$50.0K	1

Intas Pharmaceuticals Limited supplies Syringe to 18 buyers globally. The largest buyer is BROCACEF NL : HUB (NETHERLANDS), followed by AMERISOURCE HEALTH SERVICES (UNITED STATES) and ACCORD FARMACEUTICA LTDA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Syringe Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUG&MED: FULVESTRANT 250MG/5ML 1X2PFSAC-BR Each pre filled syringe of5 mL contains: Fulvestrant USP 250 mg Re	$100.0K	2
PHARMACEUTICAL DRUGS AND MEDICINE NEUGRAST EACH 1-ML PREFILLED SYRINGE CONTAINS:NEUGRAST	$100.0K	2
PHARMACEUTICAL DRUGS AND MEDICINE. ICATIBANT PFS 30MG/3ML 1P(ACCORD-FR/IE EACH 3ML PREFILLED SYRINGE CONTAIN	$95.6K	2
PHARMA DRUG&MED: FULVESTRANT 250MG/5ML 1X2PFS(AC-BR) EACH PRE FILLED SYRINGE OF5 ML CONTAINS: FULVESTRANT USP.250, MG R	$72.4K	2
PHARMACEUTICAL DRUGS AND MEDICINE-ICATIBANT PFS 30MG/3ML 1P(ACCORD-ITALY Each 3mL prefilled syringe contains Icatibant(A	$70.1K	2
PHARMA DRUG&MED: FULVESTRANT 250MG/5ML 1X2PFS(AC-BR) EACH PRE FILLED SYRINGE OF5 ML CONTAINS: FULVESTRANT USP..250 MG R	$68.3K	2
PHARM DRUG MED ICATIBANT PFS 30MG 3ML 1P ACCORD AT DE EACH 3ML PREFILLED SYRINGECONTAINS ICATIBANT ACETATE ASPERINV	$66.1K	2
PHARMA DRUG&MED:ICATIBANT PFS 30MG/3ML 3P(ACCORD-AT-DE Each 3mL prefilled syringe contains Icatibant acetate eq. to Icat	$56.6K	2
PHARM DRUG&MED:FULVESTRANT PFS250MG/5ML2PACO-ITALY EACH PREFILLED SYRINGE OF5ML CONT:FULVESTRANT PH.EURASPERINV	$50.0K	1
PHA.DRU & MEDI, FULVESTRANT INJ.50MG/ML,5ML,2PFS(BPL-US EACH PREFILLED SYRINGE OF 5 ML CONTAINS: FULVESTRANT	$50.0K	1

Intas Pharmaceuticals Limited exports 27 distinct Syringe formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUG&MED: FULVESTRANT 250MG/5ML 1X2PFSAC-BR Each pre with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Syringe Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	BRAWN LABORATORIES LIMITED	$3.1M	62	5	$50.0K
9	CONTACARE OPHTHALMICS AND DIAGNOSTICS	$1.9M	290	30	$6.7K
11	INTAS PHARMACEUTICALS LIMITED ★	$1.7M	35	11	$47.7K
6	JODAS EXPOIM PRIVATE LIMITED	$1.0M	20	2	$50.0K
14	CAPLIN POINT LABORATORIES LIMITED	$975.0K	35	4	$27.9K

Intas Pharmaceuticals Limited ranks #11 among 291 Indian Syringe exporters. Average shipment value of $47.7K compared to the market average of $231.1K. The closest competitors by value are BRAWN LABORATORIES LIMITED and CONTACARE OPHTHALMICS AND DIAGNOSTICS.

Which Indian Ports Ship Syringe Exports?

Port	Shipments	% Share
HYDERABAD ICD	447	12.7%
SAHAR AIR CARGO ACC (INBOM4)	290	8.2%
SAHAR AIR	282	8.0%
AHEMDABAD AIR	219	6.2%
AHEMDABAD AIR ACC (INAMD4)	209	5.9%
DELHI AIR	187	5.3%
NHAVA SHEVA SEA (INNSA1)	138	3.9%
HYDERABAD ICD (INSNF6)	127	3.6%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Syringe Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Syringe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 37 individual customs records matching Intas Pharmaceuticals Limited exporting Syringe, covering 27 formulations to 11 countries via 18 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 154+ countries, 751+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Syringe

Syringe

Intas Pharmaceuticals Limited — Syringe Exporter Profile

Intas Pharmaceuticals Limited — Syringe Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Syringe?

Who Are the Top Buyers of Syringe from Intas Pharmaceuticals Limited?

What Is India's Total Syringe Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Syringe Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Syringe Exporters?

What Syringe Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Syringe to Key Markets

Brazil — ANVISA

How Does Intas Pharmaceuticals Limited Compare to Nearest Syringe Exporters?

Which Indian Ports Ship Syringe Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Syringe Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Syringe Export Data from Intas Pharmaceuticals Limited

Syringe Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source